Europe Ambulatory Surgical Centers Market - 2024-2031

Report Overview

The Europe ambulatory surgical centers market reached US$ 1.1 billion in 2023 and is expected to reach US$ 5.99 billion by 2031, growing at a CAGR of 24.6% during the forecast period 2024-2031.

Ambulatory surgical centers (ASCs) are specialized healthcare facilities that offer outpatient surgical services so that patients can get treatments done without needing to stay overnight in the hospital. These facilities specialize in carrying out a wide range of surgical procedures, including gastrointestinal treatments as well as orthopedic and ophthalmology surgery. Because they provide more individualized patient care, shorter wait times, and costs that are frequently 20% to 50% less than in typical hospital settings, ASCs are gaining popularity these days.

Patients gain from a more comfortable environment and a more efficient procedure, which usually leads to quicker recovery periods and lower infection rates.

The ASC operational model places a strong emphasis on specialization and efficiency because their staff members are highly qualified professionals committed to providing outpatient care.

Market Dynamics: Drivers

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases propels the market growth. For instance, according to the World Health Organization, cardiovascular diseases (CVDs) kill approximately 10,000 people in the WHO European Region every day. They are the leading cause of death and disability in Europe, causing almost half of all deaths. Most of these deaths are from acute events such as heart attacks or strokes.

More than 60 million potential years of life are lost to CVD in Europe annually. More women than men die from CVD in Europe. Cardiovascular diseases are the leading cause of death in Germany, causing a total of approximately 40% of all deaths. Moreover, according to the World Health Organization, diabetes is one of the most common chronic conditions in the WHO European Region, and Europe has the highest burden of type 1 diabetes in the world. It is estimated that 1 in 10 people living in the Region will have diabetes by 2045.

Moreover, according to the European Commission, over 33 million people in Europe suffer from diabetes. According to IDF data, the absolute number of diabetics in Europe will rise from approximately 33 million in 2010 to 38 million in 2030. Type 2 diabetes accounts for around 90% of diabetes cases. Prediabetes affects 12% of the population. Undiagnosed type 2 diabetes accounts for more than 1 out of 3 people (36%)16 living with T2 diabetes in Europe.

Restraints

Factors such as high costs of infrastructure and deployment are expected to hamper the market. For many healthcare providers, setting up and sustaining an ASC can be too costly both initially and over time. Significant recurring expenditures are associated with operating an ASC, including pay for IT workers who oversee the facility, maintenance, and repair charges, and electricity bills for cooling systems and servers.

Market Segment Analysis

The Europe ambulatory surgical centers market is segmented based on type, specialty, service, application, and end-user.

The segment hospital-based ASCs accounted for approximately 43.5% of the Europe ambulatory surgical centers market share.

The hospital-based ASCs segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements would drive this market. Hospital-based ambulatory surgery centers are specialized establishments that offer outpatient surgical treatments, enabling patients to receive treatment without having to stay overnight in the hospital. Hospital-based ASCs function as distinct organizations with a focus on outpatient surgery even if they are integrated inside hospitals.

In response to the rising demand for same-day surgical treatments, they seek to offer a more effective and patient-centered approach to surgical care. Procedures at ASCs are usually less expensive than in conventional hospital settings. Because ASCs have lower overhead costs, patients can save anywhere from 20% to 50% on their surgery charges. Both patients and healthcare systems benefit from this financial efficiency.

Market Segmentation

By Type

Hospital-based ASCs

Free Standing ASCs

By Specialty

Single Specialty ASC

Multispecialty ASC

By Service

Diagnostics

Treatment

By Application

Gastroenterology

Ophthalmology

Orthopedics

Neurology

Dermatology

Urology

Others

By End-User

Hospitals

Specialty Clinics

Others

Market Competitive Landscape

The major players in the Europe ambulatory surgical centers market include Medtronic, Koninklijke Philips N.V., Johnson & Johnson Services Inc., Boston Scientific Corporation, and Stryker. Siemens Healthineers AG, Steris, Exactech Inc., Fujifilm Corporation, and Community Health Systems Inc. among others.

Key Developments

In September 2023, Philips launched a new image-guided therapy mobile C-arm system called Zenition 30. The Zenition 30 system is equipped with advanced imaging AI algorithms that offer surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition and reduce dependency on technician support for a wide variety of minimally invasive procedures.

Why Purchase the Report?

To visualize the Europe ambulatory surgical centers market segmentation based on type, specialty, service, application, and end-user, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of Europe ambulatory surgical centers market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The Europe ambulatory surgical centers market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies